STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
SMMT SUMMIT THERAPEUTICS INCORPORATED StockScouter® Report
1
StockScouter® Score
SUMMIT THERAPEUTICS INCORPORATED, a mid cap company in the healthcare sector, is expected to slightly underperform the market over the next six months with higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The multi-period measure of relative price change and consistency is well above average. Positive
Concerns
- The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
- Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
- One or more analysts has modestly decreased quarterly earnings estimates for SMMT. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be in favor, stocks will be , and healthcare stocks will be in favor.
Expected Risk/Return
Core Model Grades
F
C
N/A
A